Lawson Macartney

Insider Reports History

Entity
Individual
Location
C/O Ambrx, Inc., 10975 N. Torrey Pines Rd., La Jolla, CA
Signature
/s/ Michael Morneau as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lawson Macartney:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 48K $3.29M $68.67 Nov 8, 2024 Direct
Viking Therapeutics, Inc. Director Stock Option (Right to Buy) 20K Nov 8, 2024 Direct

Insider Reports Filed by Lawson Macartney

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VKTX Viking Therapeutics, Inc. Nov 8, 2024 3 -$126K 4 Nov 8, 2024 Director
VKTX Viking Therapeutics, Inc. Jan 2, 2024 1 $0 4 Jan 4, 2024 Director
VKTX Viking Therapeutics, Inc. May 16, 2023 3 -$365K 4 May 18, 2023 Director
VKTX Viking Therapeutics, Inc. Apr 24, 2023 3 -$299K 4 Apr 24, 2023 Director
VKTX Viking Therapeutics, Inc. Apr 17, 2023 3 -$249K 4 Apr 18, 2023 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 4, 2023 Director
VKTX Viking Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director